Stock listing

0K6R Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: 0K6R · LSE · USD · GB

0K6R:LSE represents Neurocrine Biosciences, Inc., a biopharmaceutical company with a market capitalization of around $17.67 billion. Neurocrine is dedicated to developing treatments for neurological and endocrine disorders, aiming to enhance patient outcomes through innovative therapies. Recent news and filings highlight the company's ongoing commitment to research and development in this specialized field. Investors can stay informed about upcoming events and market developments related to Neurocrine's advancements and strategic initiatives.

0K6R:LSEUSDGBUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
0K6R:LSE
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSE
Currency
USD

Neurocrine Biosciences, Inc. 0K6R:LSE stock context

0K6R:LSE represents Neurocrine Biosciences, Inc., a biopharmaceutical company with a market capitalization of around $17.67 billion. Neurocrine is dedicated to developing treatments for neurological and endocrine disorders, aiming to enhance patient outcomes through innovative therapies. Recent news and filings highlight the company's ongoing commitment to research and development in this specialized field. Investors can stay informed about upcoming events and market developments related to Neurocrine's advancements and strategic initiatives.

Research Neurocrine Biosciences, Inc.

Alternate listings